Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Panel Sends Mixed Message About Pfizer Drug
FDA Panel Sends Mixed Message About Pfizer Drug
FDA Panel Sends Mixed Message About Pfizer Drug
Submitted by
admin
on May 25, 2012 - 11:19am
Source:
Pharmalot
News Tags:
FDA
advisory panel
Pfizer
tafamidis
familial amyloid polyneuropathy
Headline:
FDA Panel Sends Mixed Message About Pfizer Drug
Do Not Allow Advertisers to Use My Personal information
